{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:59:00Z","timestamp":1791518340764,"version":"4.3.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T00:00:00Z","timestamp":1663632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T00:00:00Z","timestamp":1663632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Insulin-like growth factor (IGF) signaling is highly conserved and tightly regulated by proteases including Pregnancy-Associated Plasma Protein A (PAPP-A). PAPP-A and its paralog PAPP-A2 are metalloproteases that mediate IGF bioavailability through cleavage of IGF binding proteins (IGFBPs). Here, we present single-particle cryo-EM structures of the catalytically inactive mutant PAPP-A (E483A) in complex with a peptide from its substrate IGFBP5 (PAPP-A<jats:sub>BP5<\/jats:sub>) and also in its substrate-free form, by leveraging the power of AlphaFold to generate a high quality predicted model as a starting template. We show that PAPP-A is a flexible <jats:italic>trans<\/jats:italic>-dimer that binds IGFBP5 via a 25-amino acid anchor peptide which extends into the metalloprotease active site. This unique IGFBP5 anchor peptide that mediates the specific PAPP-A-IGFBP5 interaction is not found in other PAPP-A substrates. Additionally, we illustrate the critical role of the PAPP-A central domain as it mediates both IGFBP5 recognition and <jats:italic>trans<\/jats:italic>-dimerization. We further demonstrate that PAPP-A<jats:italic> trans<\/jats:italic>-dimer formation and distal inter-domain interactions are both required for efficient proteolysis of IGFBP4, but dispensable for IGFBP5 cleavage. Together the structural and biochemical studies reveal the mechanism of PAPP-A substrate binding and selectivity.<\/jats:p>","DOI":"10.1038\/s41467-022-33175-2","type":"journal-article","created":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T09:04:22Z","timestamp":1663664662000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Structure of the PAPP-ABP5 complex reveals mechanism of substrate recognition"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5917-9269","authenticated-orcid":false,"given":"Russell A.","family":"Judge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janani","family":"Sridar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8594-1074","authenticated-orcid":false,"given":"Kathryn","family":"Tunyasuvunakool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinku","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C. K.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christna","family":"Ouch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Mafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron H.","family":"Nile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clint","family":"Remarcik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey L.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crystal","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Stoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6169-6580","authenticated-orcid":false,"given":"John","family":"Jumper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amoolya H.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3933-0958","authenticated-orcid":false,"given":"Dan","family":"Eaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6246-2153","authenticated-orcid":false,"given":"Qi","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,20]]},"reference":[{"key":"33175_CR1","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ecl.2012.04.008","volume":"41","author":"S Yakar","year":"2012","unstructured":"Yakar, S. & Adamo, M. L. Insulin-like growth factor 1 physiology: lessons from mouse models. Endocrinol. Metab. Clin. North Am. 41, 231\u2013247 (2012). v.","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"33175_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-019-4492-9","volume":"12","author":"S Pouriamehr","year":"2019","unstructured":"Pouriamehr, S., Barmaki, H., Rastegary, M., Lotfi, F. & Nabi Afjadi, M. Investigation of insulin-like growth factors\/insulin-like growth factor binding proteins regulation in metabolic syndrome patients. BMC Res. Notes 12, 653 (2019).","journal-title":"BMC Res. Notes"},{"key":"33175_CR3","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1016\/S0140-6736(02)08655-5","volume":"359","author":"MS Sandhu","year":"2002","unstructured":"Sandhu, M. S. et al. Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study. Lancet 359, 1740\u20131745 (2002).","journal-title":"Lancet"},{"key":"33175_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-10-224","volume":"10","author":"JE Puche","year":"2012","unstructured":"Puche, J. E. & Castilla-Cort\u00e1zar, I. Human conditions of insulin-like growth factor-I (IGF-I) deficiency. J. Transl. Med. 10, 224 (2012).","journal-title":"J. Transl. Med."},{"key":"33175_CR5","first-page":"32","volume":"55","author":"MO Savage","year":"2001","unstructured":"Savage, M. O. et al. Growth hormone insensitivity: pathophysiology, diagnosis, clinical variation and future perspectives. Horm. Res. 55, 32\u201335 (2001).","journal-title":"Horm. Res."},{"key":"33175_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3389\/fendo.2018.00117","volume":"9","author":"JB Allard","year":"2018","unstructured":"Allard, J. B. & Duan, C. IGF-binding proteins: why do they exist and why are there so many? Front. Endocrinol. 9, 117 (2018).","journal-title":"Front. Endocrinol."},{"key":"33175_CR7","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3109\/08977194.2011.614237","volume":"29","author":"JL Martin","year":"2011","unstructured":"Martin, J. L. & Baxter, R. C. Signalling pathways of insulin-like growth factors (IGFs) and IGF binding protein-3. Growth Factors 29, 235\u2013244 (2011).","journal-title":"Growth Factors"},{"key":"33175_CR8","doi-asserted-by":"publisher","unstructured":"Bach, L. A. 40\u2009years of IGF1: IGF-binding proteins. J. Mol. Endocrinol. https:\/\/doi.org\/10.1530\/JME-18-0016 (2018).","DOI":"10.1530\/JME-18-0016"},{"key":"33175_CR9","doi-asserted-by":"publisher","first-page":"21849","DOI":"10.1074\/jbc.M102191200","volume":"276","author":"MT Overgaard","year":"2001","unstructured":"Overgaard, M. T. et al. Pregnancy-associated plasma protein-A2 (PAPP-A2), a novel insulin-like growth factor-binding protein-5 proteinase. J. Biol. Chem. 276, 21849\u201321853 (2001).","journal-title":"J. Biol. Chem."},{"key":"33175_CR10","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ando.2016.04.015","volume":"77","author":"P Monget","year":"2016","unstructured":"Monget, P. & Oxvig, C. PAPP-A and the IGF system. Ann. Endocrinol. 77, 90\u201396 (2016).","journal-title":"Ann. Endocrinol."},{"key":"33175_CR11","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s12079-015-0259-9","volume":"9","author":"C Oxvig","year":"2015","unstructured":"Oxvig, C. The role of PAPP-A in the IGF system: location, location, location. J. Cell Commun. Signal. 9, 177\u2013187 (2015).","journal-title":"J. Cell Commun. Signal."},{"key":"33175_CR12","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.15252\/emmm.201707950","volume":"9","author":"J Argente","year":"2017","unstructured":"Argente, J., Chowen, J. A., P\u00e9rez-Jurado, L. A., Frystyk, J. & Oxvig, C. One level up: abnormal proteolytic regulation of IGF activity plays a role in human pathophysiology. EMBO Mol. Med. 9, 1338\u20131345 (2017).","journal-title":"EMBO Mol. Med."},{"key":"33175_CR13","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1021\/bi00172a040","volume":"33","author":"T Kristensen","year":"1994","unstructured":"Kristensen, T., Oxvig, C., Sand, O., Moeller, N. P. H. & Sottrup-Jensen, L. Amino acid sequence of human pregnancy-associated plasma protein A derived from cloned cDNA. Biochemistry 33, 1592\u20131598 (1994).","journal-title":"Biochemistry"},{"key":"33175_CR14","doi-asserted-by":"publisher","first-page":"47225","DOI":"10.1074\/jbc.M209155200","volume":"277","author":"LS Laursen","year":"2002","unstructured":"Laursen, L. S. et al. Cell surface targeting of pregnancy-associated plasma protein A proteolytic activity. Reversible adhesion is mediated by two neighboring short consensus repeats. J. Biol. Chem. 277, 47225\u201347234 (2002).","journal-title":"J. Biol. Chem."},{"key":"33175_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1095\/biolreprod.102.007609","volume":"68","author":"P Monget","year":"2003","unstructured":"Monget, P. et al. Pregnancy-associated plasma protein-A is involved in insulin-like growth factor binding protein-2 (IGFBP-2) proteolytic degradation in bovine and porcine preovulatory follicles: identification of cleavage site and characterization of IGFBP-2 degradation. Biol. Reprod. 68, 77\u201386 (2003).","journal-title":"Biol. Reprod."},{"key":"33175_CR16","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S0014-5793(01)02760-0","volume":"504","author":"LS Laursen","year":"2001","unstructured":"Laursen, L. S. et al. Pregnancy-associated plasma protein-A (PAPP-A) cleaves insulin-like growth factor binding protein (IGFBP)\u22125 independent of IGF: implications for the mechanism of IGFBP-4 proteolysis by PAPP-A. FEBS Lett. 504, 36\u201340 (2001).","journal-title":"FEBS Lett."},{"key":"33175_CR17","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3389\/fendo.2020.00597","volume":"11","author":"C Duan","year":"2020","unstructured":"Duan, C. & Allard, J. B. Corrigendum: insulin-like growth factor binding protein-5 in physiology and disease. Front. Endocrinol. 11, 597 (2020).","journal-title":"Front. Endocrinol."},{"key":"33175_CR18","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1210\/endo.142.6.8192","volume":"142","author":"N Miyakoshi","year":"2001","unstructured":"Miyakoshi, N. et al. Systemic administration of Insulin-like Growth Factor (IGF)-Binding Protein-4 (IGFBP-4) increases bone formation parameters in mice by increasing IGF bioavailability via an IGFBP-4 protease-dependent mechanism*. Endocrinology 142, 2641\u20132648 (2001).","journal-title":"Endocrinology"},{"key":"33175_CR19","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1210\/js.2018-00106","volume":"2","author":"M Andrew","year":"2018","unstructured":"Andrew, M. et al. PAPPA2 as a therapeutic modulator of IGF-I bioavailability: in vivo and in vitro evidence. J. Endocr. Soc. 2, 646\u2013656 (2018).","journal-title":"J. Endocr. Soc."},{"key":"33175_CR20","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.ghir.2015.07.001","volume":"25","author":"JK Christians","year":"2015","unstructured":"Christians, J. K., Bath, A. K. & Amiri, N. Pappa2 deletion alters IGFBPs but has little effect on glucose disposal or adiposity. Growth Horm. IGF Res. 25, 232\u2013239 (2015).","journal-title":"Growth Horm. IGF Res."},{"key":"33175_CR21","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1210\/jc.2009-2277","volume":"95","author":"X Yan","year":"2010","unstructured":"Yan, X., Baxter, R. C. & Firth, S. M. Involvement of pregnancy-associated plasma protein-A2 in Insulin-like Growth Factor (IGF) binding Protein-5 proteolysis during pregnancy: a potential mechanism for increasing IGF bioavailability. J. Clin. Endocrinol. Metab. 95, 1412\u20131420 (2010).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"33175_CR22","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1074\/jbc.M208777200","volume":"278","author":"MT Overgaard","year":"2003","unstructured":"Overgaard, M. T. et al. Complex of pregnancy-associated plasma protein-A and the proform of eosinophil major basic protein: disulfide structure and carbohydrate attachment sites. J. Biol. Chem. 278, 2106\u20132117 (2003).","journal-title":"J. Biol. Chem."},{"key":"33175_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/190178","volume":"2013","author":"P D\u2019Elia","year":"2013","unstructured":"D\u2019Elia, P. et al. Analysis of pregnancy-associated plasma protein A production in human adult cardiac progenitor cells. BioMed. Res. Int. 2013, 1\u20138 (2013).","journal-title":"BioMed. Res. Int."},{"key":"33175_CR24","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.abb.2004.01.005","volume":"423","author":"AS Sivanandam","year":"2004","unstructured":"Sivanandam, A. S. et al. Covalent interaction between proform of eosinophil major basic protein (proMBP) and pregnancy-associated plasma protein-A (PAPP-A) is a cell-mediated event and required for proMBP inhibition of the catalytic activity of PAPP-A. Arch. Biochem. Biophysics 423, 343\u2013350 (2004).","journal-title":"Arch. Biochem. Biophysics"},{"key":"33175_CR25","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.3109\/00016349.2010.505639","volume":"89","author":"I Kirkegaard","year":"2010","unstructured":"Kirkegaard, I., Uldbjerg, N. & Oxvig, C. Biology of pregnancy-associated plasma protein-A in relation to prenatal diagnostics: an overview. Acta Obstet. Gynecol. Scand. 89, 1118\u20131125 (2010).","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"33175_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4274\/jcrpe.3378","volume":"9","author":"M Fujimoto","year":"2017","unstructured":"Fujimoto, M., Hwa, V. & Dauber, A. Novel modulators of the growth hormone\u2014insulin-like growth factor axis: Pregnancy-associated plasma protein-A2 and stanniocalcin-2. J. Clin. Res. Pediatr. Endocrinol. 9, 1\u20138 (2017).","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"key":"33175_CR27","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1093\/humrep\/dew013","volume":"31","author":"MR Jepsen","year":"2016","unstructured":"Jepsen, M. R. et al. The proteolytic activity of pregnancy-associated plasma protein-A is potentially regulated by stanniocalcin-1 and \u22122 during human ovarian follicle development. Hum. Reprod. 31, 866\u2013874 (2016).","journal-title":"Hum. Reprod."},{"key":"33175_CR28","doi-asserted-by":"publisher","first-page":"21915","DOI":"10.1074\/jbc.M115.650143","volume":"290","author":"S Kl\u00f8verpris","year":"2015","unstructured":"Kl\u00f8verpris, S. et al. Stanniocalcin-1 potently inhibits the proteolytic activity of the metalloproteinase pregnancy-associated plasma protein-A. J. Biol. Chem. 290, 21915\u201321924 (2015).","journal-title":"J. Biol. Chem."},{"key":"33175_CR29","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.1074\/jbc.M114.611665","volume":"290","author":"MR Jepsen","year":"2015","unstructured":"Jepsen, M. R. et al. Stanniocalcin-2 inhibits mammalian growth by proteolytic inhibition of the insulin-like growth factor axis. J. Biol. Chem. 290, 3430\u20133439 (2015).","journal-title":"J. Biol. Chem."},{"key":"33175_CR30","doi-asserted-by":"publisher","first-page":"12243","DOI":"10.1016\/S0021-9258(18)31378-4","volume":"268","author":"C Oxvig","year":"1993","unstructured":"Oxvig, C., Sand, O., Kristensen, T., Gleich, G. J. & Sottrup-Jensen, L. Circulating human pregnancy-associated plasma protein-A is disulfide-bridged to the proform of eosinophil major basic protein. J. Biol. Chem. 268, 12243\u201312246 (1993).","journal-title":"J. Biol. Chem."},{"key":"33175_CR31","doi-asserted-by":"publisher","first-page":"31128","DOI":"10.1074\/jbc.M001384200","volume":"275","author":"MT Overgaard","year":"2000","unstructured":"Overgaard, M. T. et al. Expression of recombinant human pregnancy-associated plasma protein-A and identification of the proform of eosinophil major basic protein as its physiological inhibitor. J. Biol. Chem. 275, 31128\u201331133 (2000).","journal-title":"J. Biol. Chem."},{"key":"33175_CR32","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1111\/j.1474-9726.2007.00328.x","volume":"6","author":"CA Conover","year":"2007","unstructured":"Conover, C. A. & Bale, L. K. Loss of pregnancy-associated plasma protein A extends lifespan in mice. Aging Cell 6, 727\u2013729 (2007).","journal-title":"Aging Cell"},{"key":"33175_CR33","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1111\/j.1474-9726.2010.00630.x","volume":"9","author":"CA Conover","year":"2010","unstructured":"Conover, C. A. PAPP-A: a new anti-aging target? Aging Cell 9, 942\u2013946 (2010).","journal-title":"Aging Cell"},{"key":"33175_CR34","doi-asserted-by":"publisher","first-page":"11252","DOI":"10.1073\/pnas.0807025106","volume":"106","author":"AN Vallejo","year":"2009","unstructured":"Vallejo, A. N. et al. Resistance to age-dependent thymic atrophy in long-lived mice that are deficient in pregnancy-associated plasma protein A. Proc. Natl Acad. Sci. USA 106, 11252\u201311257 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"33175_CR35","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583\u2013589 (2021).","journal-title":"Nature"},{"key":"33175_CR36","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1042\/bj20020831","volume":"367","author":"LS Laursen","year":"2002","unstructured":"Laursen, L. S. et al. Substrate specificity of the metalloproteinase pregnancy-associated plasma protein-A (PAPP-A) assessed by mutagenesis and analysis of synthetic peptides: substrate residues distant from the scissile bond are critical for proteolysis. Biochem. J. 367, 31\u201340 (2002).","journal-title":"Biochem. J."},{"key":"33175_CR37","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1042\/bj3580359","volume":"358","author":"HB Boldt","year":"2001","unstructured":"Boldt, H. B. et al. Mutational analysis of the proteolytic domain of pregnancy-associated plasma protein-A (PAPP-A): classification as a metzincin. Biochemical J. 358, 359 (2001).","journal-title":"Biochemical J."},{"key":"33175_CR38","doi-asserted-by":"publisher","first-page":"10988","DOI":"10.1074\/jbc.M607903200","volume":"282","author":"K Weyer","year":"2007","unstructured":"Weyer, K. et al. A substrate specificity-determining unit of three Lin12-Notch repeat modules is formed in trans within the pappalysin-1 dimer and requires a sequence stretch C-terminal to the third module. J. Biol. Chem. 282, 10988\u201310999 (2007).","journal-title":"J. Biol. Chem."},{"key":"33175_CR39","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fendo.2018.00031","volume":"9","author":"J Beattie","year":"2018","unstructured":"Beattie, J. et al. Insulin- like growth factor-binding protein action in bone tissue: a key role for pregnancy- associated plasma protein-A. Front. Endocrinol. 9, 31 (2018).","journal-title":"Front. Endocrinol."},{"key":"33175_CR40","doi-asserted-by":"publisher","first-page":"17920","DOI":"10.1074\/jbc.M600907200","volume":"281","author":"C Tallant","year":"2006","unstructured":"Tallant, C., Garc\u00eda-Castellanos, R., Seco, J., Baumann, U. & Gomis-R\u00fcth, F. X. Molecular analysis of ulilysin, the structural prototype of a new family of metzincin metalloproteases. J. Biol. Chem. 281, 17920\u201317928 (2006).","journal-title":"J. Biol. Chem."},{"key":"33175_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-49626-8","volume":"9","author":"JA B\u00f8tkj\u00e6r","year":"2019","unstructured":"B\u00f8tkj\u00e6r, J. A., Noer, P. R., Oxvig, C. & Yding Andersen, C. A common variant of the pregnancy-associated plasma protein-A (PAPPA) gene encodes a protein with reduced proteolytic activity towards IGF-binding proteins. Sci. Rep. 9, 13231 (2019).","journal-title":"Sci. Rep."},{"key":"33175_CR42","doi-asserted-by":"publisher","first-page":"38525","DOI":"10.1074\/jbc.M405222200","volume":"279","author":"HB Boldt","year":"2004","unstructured":"Boldt, H. B. et al. The Lin12-notch repeats of pregnancy-associated plasma protein-A bind Calcium and determine its proteolytic specificity*. J. Biol. Chem. 279, 38525\u201338531 (2004).","journal-title":"J. Biol. Chem."},{"key":"33175_CR43","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1002\/prot.26350","volume":"90","author":"G Jaipuria","year":"2022","unstructured":"Jaipuria, G. et al. IGF-dependent dynamic modulation of a protease cleavage site in the intrinsically disordered linker domain of human IGFBP2. Proteins 90, 1732\u20131743 (2022).","journal-title":"Proteins"},{"key":"33175_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32214-2","volume":"13","author":"H Kim","year":"2022","unstructured":"Kim, H. et al. Structural basis for assembly and disassembly of the IGF\/IGFBP\/ALS ternary complex. Nat. Commun. 13, 4434 (2022).","journal-title":"Nat. Commun."}],"updated-by":[{"DOI":"10.1038\/s41467-022-33522-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T00:00:00Z","timestamp":1664323200000}}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-33175-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-33175-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-33175-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T11:06:27Z","timestamp":1666523187000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-33175-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,20]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["33175"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-33175-2","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41467-022-33522-3","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,20]]},"assertion":[{"value":"31 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41467-022-33522-3","URL":"https:\/\/doi.org\/10.1038\/s41467-022-33522-3","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.S. J.C.K.W, J.X., A.M., A.H.N., C.R., C.G., D.E. and Q.H. are employees of Calico Life Sciences LLC and declare no other competing interests. R.A.J, R.J., C.L.S and V.S. are employees of AbbVie and own AbbVie stocks. K.T. and J.J. are employees of DeepMind. J.J. has filed non-provisional patent applications 16\/701,070 and PCT\/EP2020\/084238, PCT\/EP2021\/072552, PCT\/EP2021\/082684, PCT\/EP2021\/082696, PCT\/EP2021\/082698 and PCT\/EP2021\/082707, each in the name of DeepMind Technologies Limited, each pending, relating to machine learning for predicting protein structures. C.O. and C.X. declare no competing interests. AbbVie, Calico, and DeepMind contributed financial support for the study and participated in the design, conduct, data analysis, review and approval of the publication.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5500"}}